Dogs that have been infected with multiple influenza viruses have the potential to act as "mixing vessels" and generate new flu strains that could infect people, researchers said.
Today, veterinarians use vaccines that include inactivated or killed flu virus, but experts say they provide short-term, limited protection.
Scientists led by Luis Martinez-Sobrido from University of Rochester in the US created two "live-attenuated" vaccines against H3N8 canine influenza virus, which is currently circulating in dogs in the US.
Researchers used a genetic engineering technique called reserve genetics to create a live vaccine that replicates in the nose, but not in the lungs.
The nose is where the virus first enters a dog's body, so generating an immune response there could stop the virus in its tracks.
If the vaccine were to get into the lungs it could create unwanted inflammation in response to the live virus.
In a second study the team used reserve genetics to remove a protein called NS1 from H3N8 canine influenza virus.
Previous studies have shown that deleting the NS1 viral protein significantly weakens flu viruses so that they elicit an immune response but don't cause illness.
This approach has been used with human, swine and equine flu viruses to generate potential vaccines and was also safe and more effective than a traditional inactivated H3N8 influenza vaccine in mice and dog tracheal cells.
The team is using this research to tackle other dog flu viruses, too. They have used the safety of these approaches to engineer a live-attenuated vaccine for the H3N2 canine influenza virus, which was introduced in the US in 2015.
Early results show that similar to the H3N8 vaccine, the H3N2 live-attenuated vaccine is able to protect against the H3N2 canine influenza virus and is more effective than the only currently available inactivated vaccine.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
